Recall archive / FDA drug enforcement
TESTO-100 CIII (testosterone 100 mg), 10 Sterile Pellets per carton, Rx only, Manufactured by: Advanced Pharmaceutica... — FDA record D-0258-2026
Reported ongoing
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Oct 3, 2025. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- TESTO-100 CIII (testosterone 100 mg), 10 Sterile Pellets per carton, Rx only, Manufactured by: Advanced Pharmaceutical Technology, 132 South Central Avenue, Elmsford, NY 10523, NDC# 57377-100-01
- Reason
- Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets.
- Classification
- Class II
- Recalling firm
- Advanced Pharmaceutical Technology, Inc.
- Quantity
- 22,843 pellets
- Agency-reported status
- Ongoing
- Source record identifier
- D-0258-2026
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Lot #: P-22-3, Exp 06-2027 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
GA, NY, TX, Puerto Rico, United Kingdom, Malta, Greece
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
Dates in the source
- Report date
- Jan 21, 2026
- Recall initiation date
- Oct 3, 2025
- Center classification date
- Jan 14, 2026
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.